MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/curroncol33050275

Медицинская библиотека · Current oncology (Toronto, Ont.) · 2026

Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey.

Dragan Tatiana, Hubel Niclas, Lehmann Jens, Taylor Katherine J, Bultijnck Renée, Gašpert Tihana, Lorini Luigi, Bourbonne Vincent, Beddok Arnaud, Tomasik Bartłomiej, Nevens Daan, Cavalieri Stefano, Gómez Ruth Gabriela Herrera, Looman Esmée Lauren, Zsuzsanna Iyizoba-Ebozue, Kraja Fatjona, Lidington Emma, Lengyel Csongor György, Oliva Marc, Petruzzi Gerardo, Gomes Ana Varges, Hernandez Maria Pilar Solis, Zanten Sophie Veldhuijzen van, Brenes Castro Jesus, Caparrotti Francesca, Fanetti Giuseppe, Eller Yannick G, Gottardi Chiara, Wishart Laurelie R, Szturz Petr

СтатьяПеревод пока не подготовлен

Аннотация

Background

Head and neck cancer (HNC) and its multimodal treatment substantially impair speech, swallowing, breathing, appearance, and psychosocial well-being. Patient-reported outcome measures (PROMs) improve symptom monitoring and quality of life in oncology, yet their integration into routine HNC care remains inconsistent. This study assessed patterns of PROM use, perceived value, and barriers to implementation among healthcare professionals (HCPs) involved in HNC care.

Methods

A 30-item cross-sectional survey was distributed to HCPs treating HNC patients between June 2024 and April 2025. The questionnaire explored PROM use in clinical practice and trials, perceived relevance across care phases, and implementation barriers. Respondents were classified as non-users, occasional users, or regular users. Data were analyzed descriptively with comparisons between groups.

Results

Among 133 respondents, 33.8% were non-users, 29.3% occasional users, and 36.8% regular users of PROMs. Users reported inviting half of patients to complete PROMs, predominantly via paper-based questionnaires (67.8%). PROMs were mainly applied during active treatment and early follow-up to monitor symptoms, overall health, and emotional well-being, and were less frequently used to guide treatment decisions. The EORTC QLQ-C30 and HNC-specific tools were most commonly reported. Compared with users, non-users more often cited lack of time, limited training in interpreting PROM data, insufficient institutional support, resource constraints, and lack of appropriate instruments (all p < 0.05). PROM use in clinical trials was associated with routine use (p < 0.001).

Conclusions

Although PROMs are widely valued in HNC care, their integration into clinical decision-making remains limited. Addressing organizational, educational, and digital barriers is essential to support sustainable implementation.

Для цитирования: Dragan Tatiana, Hubel Niclas, Lehmann Jens, Taylor Katherine J, Bultijnck Renée, Gašpert Tihana, Lorini Luigi, Bourbonne Vincent, Beddok Arnaud, Tomasik Bartłomiej, Nevens Daan, Cavalieri Stefano, Gómez Ruth Gabriela Herrera, Looman Esmée Lauren, Zsuzsanna Iyizoba-Ebozue, Kraja Fatjona, Lidington Emma, Lengyel Csongor György, Oliva Marc, Petruzzi Gerardo, Gomes Ana Varges, Hernandez Maria Pilar Solis, Zanten Sophie Veldhuijzen van, Brenes Castro Jesus, Caparrotti Francesca, Fanetti Giuseppe, Eller Yannick G, Gottardi Chiara, Wishart Laurelie R, Szturz Petr. Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey.. Current oncology (Toronto, Ont.). 2026. DOI: 10.3390/curroncol33050275.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.